HECTOR DESCAMPS: Open Payments
NPI 1902851751 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 16 payments from 5 companies in 2025. Trend: 2023 $315 · 2024 $434 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 9 | $172 |
| Amgen Inc. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| ABBVIE INC. | 1 | $16 |
Products named: ZENPEP, LEQVIO, OTEZLA, AIRSUPRA, REPATHA, LINZESS.
Industry payments across FL — which companies pay providers there.
